Vaxart (NASDAQ: VXRT) reported Q2 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $66.67 thousand.

For earnings history and earnings-related data on Vaxart (VXRT) click here.